Flucelvax Quadrivalent FDA Approval History
FDA Approved: Yes (First approved May 23, 2016)
Brand name: Flucelvax Quadrivalent
Generic name: influenza virus vaccine, inactivated
Company: Seqirus
Treatment for: Influenza Prophylaxis
Last updated by Judith Stewart, BPharm on Sep 8, 2021.
Flucelvax Quadrivalent is an inactivated influenza vaccine indicated for active immunization for active immunization against influenza disease in people 2 years of age and older.
Development timeline for Flucelvax Quadrivalent
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.